ECSP982698A - PROSTAGLANDIN AGONISTS - Google Patents

PROSTAGLANDIN AGONISTS

Info

Publication number
ECSP982698A
ECSP982698A ECSP982698A ECSP982698A EC SP982698 A ECSP982698 A EC SP982698A EC SP982698 A ECSP982698 A EC SP982698A EC SP982698 A ECSP982698 A EC SP982698A
Authority
EC
Ecuador
Prior art keywords
prostaglandin agonists
agonists
prostaglandin
prostagalndin
useful
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Bruce Allen Lefker
Robert L Rosati
Kimberly O'keefe Cameron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982698 priority Critical patent/ECSP982698A/en
Publication of ECSP982698A publication Critical patent/ECSP982698A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invención se refiere a agonistas de prostaglandinas, a procedimientos para utilizar dichos agonistas de prostagalndinas, a composiciones farmacéuticas que contienen dichos agonistas de prostaglandinas y a estuches que contienen dichos agonistas de prostaglandinas. Los agonistas de prostaglandinas son útiles para el tratamiento de los trastornos óseo, incluyendo la osteoporosis.This invention relates to prostaglandin agonists, to methods of using said prostagalndin agonists, to pharmaceutical compositions containing said prostaglandin agonists and to kits containing said prostaglandin agonists. Prostaglandin agonists are useful for the treatment of bone disorders, including osteoporosis.

ECSP982698 1998-10-16 1998-10-16 PROSTAGLANDIN AGONISTS ECSP982698A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982698 ECSP982698A (en) 1998-10-16 1998-10-16 PROSTAGLANDIN AGONISTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982698 ECSP982698A (en) 1998-10-16 1998-10-16 PROSTAGLANDIN AGONISTS

Publications (1)

Publication Number Publication Date
ECSP982698A true ECSP982698A (en) 1999-04-16

Family

ID=42043616

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982698 ECSP982698A (en) 1998-10-16 1998-10-16 PROSTAGLANDIN AGONISTS

Country Status (1)

Country Link
EC (1) ECSP982698A (en)

Similar Documents

Publication Publication Date Title
HN1998000157A (en) PROSTAGLANDIN AGONISTS
PA8452701A1 (en) PROSTAGLANDIN AGONISTS
CO4910163A1 (en) PREVENTION OF THE LOSS AND RESTORATION OF THE BONE MASS BY CERTAIN PROSTAGLANDIN AGONISTS
AR005987A1 (en) COMBINED THERAPY FOR OSTEOPOROSIS
BR9804437A (en) Compounds for osteoporosis
PT1305286E (en) CYCLOPENTANOINDOLES COMPOSITIONS CONTAINING THE REFERRED COMPOUNDS AND METHODS OF TREATMENT
ES2139959T3 (en) STYLENE DERIVATIVES USEFUL AS CYCLOOXYGENASE-2 INHIBITORS.
AR023423A1 (en) ADAMANTAN DERIVATIVES, PROCEDURES FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION, PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF MEDICINES
ES2183937T3 (en) INHIBITORS OF THE CELL ADHESION.
ECSP045520A (en) TREATMENT METHODS WITH PTEC INHIBITORS AND ANTIHIPERTENSIVE AGENTS
CR20120007A (en) 2-INDOLINONES REPLACED WITH PROTEINQUINASE INHIBITING PIRROLS (DIVISIONAL EXP. 6728)
PA8583401A1 (en) NEW TRIAZOL COMPOUNDS AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF)
ES2175231T3 (en) NEW ACTIVATED AMPHETAMINS.
UY26656A1 (en) "METABOLITES AGONISTS / ANTAGONISTS OF ESTROGEN"
NO20014241D0 (en) C16-unsaturated FP-selective prostaglandin analogs
ECSP003590A (en) CALCIOLITIC COMPOUNDS
ECSP982698A (en) PROSTAGLANDIN AGONISTS
ECSP982554A (en) PROSTAGLANDIN AGONISTS
ES2175661T3 (en) DERIVATIVES OF ISOFLAVONA, PROCEDURES FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
BR9811819A (en) 2-acylaminopropanamines as tachykinin receptor antagonists
UY27815A1 (en) USEFUL PROSTAGLANDIN AGONISTS IN THE TREATMENT OF OSE DISORDERS
BR9904146A (en) Therapeutic combinations that include a selective modulator of estrogen and protaglandin e2 receptors.
PA8469801A1 (en) PROCEDURE FOR PREPARING PHENOXYPHENYL SULFONYL HALIDES
UY26651A1 (en) COMBINED THERAPY FOR OSTEOPOROSIS
ECSP972347A (en) PREVENTION OF LOSS AND RESTORATION OF THE BONE MASS BY CERTAIN PROSTAGLANDIN AGONISTS